Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Gallagher

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Spinal Cord|October 18, 2000
Parathyroid hormone-related protein (1-34) and urothelial redifferentiation in the neuropathic urinary bladderS Vaidyanathan, I W McDicken, P Mansour, et al.
Scientific Reports|July 13, 2019
Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of AlkaptonuriaA M Milan, A T Hughes, A S Davison, et al.
Metabolomics : Official Journal of the Metabolomic Society|May 1, 2019
Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imagingA S Davison, N Strittmatter, H Sutherland, et al.
Molecular Genetics and Metabolism|June 9, 2022
Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuriaL R Ranganath, A T Hughes, A S Davison, et al.
Osteoarthritis and Cartilage|May 1, 2012
Ochronosis in a murine model of alkaptonuria is synonymous to that in the human conditionA M Taylor, A J Preston, N K Paulk, et al.
Scientific Reports|September 28, 2022
Determinants of tyrosinaemia during nitisinone therapy in alkaptonuriaL R Ranganath, A M Milan, A T Hughes, et al.
Molecular Genetics and Metabolism|July 28, 2018
Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinoneA S Davison, J A Harrold, G Hughes, et al.
Journal of Anatomy|August 19, 2014
On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritisA Boyde, G R Davis, D Mills, et al.
Journal of Inherited Metabolic Disease|March 15, 2024
Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuriaB P Norman, H Sutherland, P J M Wilson, et al.
Molecular Genetics and Metabolism Reports|March 4, 2022
Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuriaL R Ranganath, A M Milan, A T Hughes, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Spinal Cord|October 18, 2000
Parathyroid hormone-related protein (1-34) and urothelial redifferentiation in the neuropathic urinary bladderS Vaidyanathan, I W McDicken, P Mansour, et al.
Scientific Reports|July 13, 2019
Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of AlkaptonuriaA M Milan, A T Hughes, A S Davison, et al.
Metabolomics : Official Journal of the Metabolomic Society|May 1, 2019
Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imagingA S Davison, N Strittmatter, H Sutherland, et al.
Molecular Genetics and Metabolism|June 9, 2022
Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuriaL R Ranganath, A T Hughes, A S Davison, et al.
Osteoarthritis and Cartilage|May 1, 2012
Ochronosis in a murine model of alkaptonuria is synonymous to that in the human conditionA M Taylor, A J Preston, N K Paulk, et al.
Scientific Reports|September 28, 2022
Determinants of tyrosinaemia during nitisinone therapy in alkaptonuriaL R Ranganath, A M Milan, A T Hughes, et al.
Molecular Genetics and Metabolism|July 28, 2018
Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinoneA S Davison, J A Harrold, G Hughes, et al.
Journal of Anatomy|August 19, 2014
On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritisA Boyde, G R Davis, D Mills, et al.
Journal of Inherited Metabolic Disease|March 15, 2024
Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuriaB P Norman, H Sutherland, P J M Wilson, et al.
Molecular Genetics and Metabolism Reports|March 4, 2022
Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuriaL R Ranganath, A M Milan, A T Hughes, et al.
Pageof 12